the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C

NCT06132360 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

To Reduce the LDL-C Level in Hypercholesteremia Patients

Interventions

DRUG: RN0191

Sponsor

Shanghai Rona Therapeutics Co., Ltd.